205 related articles for article (PubMed ID: 38543535)
21. Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association.
Kneis B; Wirtz S; Weber K; Denz A; Gittler M; Geppert C; Brunner M; Krautz C; Siebenhüner AR; Schierwagen R; Tyc O; Agaimy A; Grützmann R; Trebicka J; Kersting S; Langheinrich M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834671
[TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.
Pandey H; Tang DWT; Wong SH; Lal D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765824
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota Eubacterium callanderi Exerts Anti-Colorectal Cancer Activity.
Ryu SW; Kim JS; Oh BS; Choi WJ; Yu SY; Bak JE; Park SH; Kang SW; Lee J; Jung WY; Lee JS; Lee JH
Microbiol Spectr; 2022 Dec; 10(6):e0253122. PubMed ID: 36448791
[TBL] [Abstract][Full Text] [Related]
24. Intestinal Microbiota in Colorectal Adenoma-Carcinoma Sequence.
Hua H; Sun Y; He X; Chen Y; Teng L; Lu C
Front Med (Lausanne); 2022; 9():888340. PubMed ID: 35935780
[TBL] [Abstract][Full Text] [Related]
25. Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice.
Tian Y; Zuo L; Guan B; Wu H; He Y; Xu Z; Shen M; Hu J; Qian J
Nutrition; 2022 Oct; 102():111712. PubMed ID: 35802940
[TBL] [Abstract][Full Text] [Related]
26. Mutational Pattern Induced by 5-Fluorouracil and Oxaliplatin in the Gut Microbiome.
Wan L; Li H; Sun G; Zhang L; Xu H; Su F; He S; Xiao F
Front Microbiol; 2022; 13():841458. PubMed ID: 35572679
[TBL] [Abstract][Full Text] [Related]
27. Microbiota in health and diseases.
Hou K; Wu ZX; Chen XY; Wang JQ; Zhang D; Xiao C; Zhu D; Koya JB; Wei L; Li J; Chen ZS
Signal Transduct Target Ther; 2022 Apr; 7(1):135. PubMed ID: 35461318
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
29. Intestinal microbiota profiles in a genetic model of colon tumorigenesis correlates with colon cancer biomarkers.
Vitali F; Tortora K; Di Paola M; Bartolucci G; Menicatti M; De Filippo C; Caderni G
Sci Rep; 2022 Jan; 12(1):1432. PubMed ID: 35082322
[TBL] [Abstract][Full Text] [Related]
30. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Kim J; Lee HK
Front Immunol; 2021; 12():807648. PubMed ID: 35069592
[TBL] [Abstract][Full Text] [Related]
31. Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy.
Zhu J; Su J
Indian J Microbiol; 2022 Mar; 62(1):23-31. PubMed ID: 35068600
[TBL] [Abstract][Full Text] [Related]
32. The interaction between gut microbiome and anti-tumor drug therapy.
Fu C; Yang Z; Yu J; Wei M
Am J Cancer Res; 2021; 11(12):5812-5832. PubMed ID: 35018227
[TBL] [Abstract][Full Text] [Related]
33. Identification of microbial markers across populations in early detection of colorectal cancer.
Wu Y; Jiao N; Zhu R; Zhang Y; Wu D; Wang AJ; Fang S; Tao L; Li Y; Cheng S; He X; Lan P; Tian C; Liu NN; Zhu L
Nat Commun; 2021 May; 12(1):3063. PubMed ID: 34031391
[TBL] [Abstract][Full Text] [Related]
34. Anticancer effects of bifidobacteria on colon cancer cell lines.
Faghfoori Z; Faghfoori MH; Saber A; Izadi A; Yari Khosroushahi A
Cancer Cell Int; 2021 May; 21(1):258. PubMed ID: 33980239
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
[TBL] [Abstract][Full Text] [Related]
36. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
37. The DNA Glycosylase NEIL2 Suppresses
Sayed IM; Chakraborty A; Abd El-Hafeez AA; Sharma A; Sahan AZ; Huang WJM; Sahoo D; Ghosh P; Hazra TK; Das S
Cells; 2020 Aug; 9(9):. PubMed ID: 32872214
[TBL] [Abstract][Full Text] [Related]
38.
Casasanta MA; Yoo CC; Udayasuryan B; Sanders BE; Umaña A; Zhang Y; Peng H; Duncan AJ; Wang Y; Li L; Verbridge SS; Slade DJ
Sci Signal; 2020 Jul; 13(641):. PubMed ID: 32694172
[No Abstract] [Full Text] [Related]
39. The Human Microbiome and Its Impacts on Health.
Ogunrinola GA; Oyewale JO; Oshamika OO; Olasehinde GI
Int J Microbiol; 2020; 2020():8045646. PubMed ID: 32612660
[TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
Serna G; Ruiz-Pace F; Hernando J; Alonso L; Fasani R; Landolfi S; Comas R; Jimenez J; Elez E; Bullman S; Tabernero J; Capdevila J; Dienstmann R; Nuciforo P
Ann Oncol; 2020 Oct; 31(10):1366-1375. PubMed ID: 32569727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
